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Activation of the VEGFR-3 Pathway by VEGF-C
Attenuates UVB-Induced Edema Formation and Skin
Inflammation by Promoting Lymphangiogenesis
Kentaro Kajiya1, Mika Sawane1, Reto Huggenberger2 and Michael Detmar2
We have previously demonstrated that UVB irradiation resulted in impaired function of cutaneous lymphatic
vessels, suggesting a crucial role of lymphatic function in the mediation of UVB-induced inflammation.
Nonetheless, the molecular mechanisms of lymphatic involvement in inflammation have remained unclear.
Here, we show that vascular endothelial growth factor (VEGF)-C expression is downregulated after UVB
irradiation, associated with enlargement of lymphatic vessels and with an increase of macrophage infiltration in
the dermis. To determine whether activation of VEGF-C/VEGFR-3 signaling might reduce UVB-induced
inflammation, mice were exposed to a single dose of UVB irradiation together with intradermal injection of
mutant VEGF-C (Cys156Ser), which specifically binds to VEGFR-3 on lymphatic endothelium. We found that the
activation of VEGFR-3 attenuated UVB-induced edema formation, associated with a decreased number of
CD11b-positive macrophages. Moreover, mutant VEGF-C injection inhibited UVB-induced enlargement of
lymphatic vessels and also induced the proliferation of lymphatic endothelial cells. In contrast, treatment with
mutant VEGF-C had no effect on blood vessel size or number. These results demonstrate that UVB-induced
lymphatic impairment is mediated by downregulation of VEGF-C expression and that the activation of the VEGF-
C/VEGFR-3 pathway might represent a feasible target for the prevention of UVB-induced inflammation by
promoting lymphangiogenesis.
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INTRODUCTION
Acute exposure of skin to UVB irradiation (290–320 nm) leads
to epidermal hyperplasia, erythema, vascular hyperperme-
ability, and edema formation (Kligman, 1989; Cox et al.,
1992; Kripke, 1994). We have previously found that
pronounced blood vascular angiogenesis is induced by acute
UVB irradiation of human and mouse skin (Yano et al., 2004,
2005). Angiogenesis induced by UVB irradiation is mediated
by upregulation of several angiogenesis factors, including
vascular endothelial growth factor (VEGF)-A, basic fibroblast
growth factor and IL-8 (Kramer et al., 1993; Strickland et al.,
1997; Yano et al., 2004) and by downregulation of the
endogeneous angiogenesis inhibitor thrombospondin-1
(Howell et al., 2004; Yano et al., 2004). Moreover, targeted
overexpression of VEGF-A in the epidermis enhances the
sensitivity to UVB-induced cutaneous photodamage (Hirakawa
et al., 2005), whereas overexpression of thrombospondin-1 in
the epidermis prevents UVB-induced photodamage (Yano
et al., 2002). Taken together, these findings clearly indicate
that the cutaneous blood vasculature plays an important
functional role in the mediation of the UVB effects on the
skin. In contrast, the role of the lymphatic vascular system in
the mediation of the cutaneous UVB response has remained
unclear.
The cutaneous lymphatic vascular system consists of a
dense network of thin-walled capillaries that drain protein-
rich lymph from the extracellular space. Lymphatic vessels
have a major role in the maintenance of tissue fluid
homeostasis and in the mediation of the afferent immune
response (Oliver and Detmar, 2002; Oliver and Alitalo,
2005). Previously, VEGF-C and VEGF-D were identified as
potent skin lymphangiogenesis factors, acting via the VEGF
receptor-3 (VEGFR-3) that is specifically expressed on
lymphatic endothelial cells (Jussila and Alitalo, 2002).
Targeted overexpression of a soluble VEGFR-3—which
inhibits the interaction of VEGF-C and VEGF-D with
membrane-bound VEGFR-3 on lymphatic endothelium—in
the skin of transgenic mice results in lymphedema (Makinen
et al., 2001), whereas transgenic overexpression of VEGF-C
in the epidermis promotes cutaneous lymphangiogenesis
(Jeltsch et al., 1997). Research into the lymphatic vascular
system has been hampered for decades by the lack of reliable
markers that distinguish lymphatic from blood vessels.
However, the recent discovery of lymphatic-specific markers
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such as the homeobox transcription factor Prox1, the
hyaluronan receptor LYVE-1, and the mucin-type transmem-
brane glycoprotein podoplanin has provided new opportu-
nities for lymphatic research, leading to the surprising finding
that lymphatic vessels play an active role in inflammation and
in the metastatic spread of cancers (Oliver and Detmar, 2002;
Alitalo et al., 2005; Cao, 2005; Tobler and Detmar, 2006).
Recently, we found that lymphatic vessels are reduced in
photoaged human skin (Kajiya et al., 2007, 2008) and that
chronic UVB irradiation of the skin induced hyperperme-
ability of cutaneous lymphatic vessels, resulting in impaired
lymphatic drainage function (Kajiya et al., 2006). Moreover,
blockade of VEGFR-3 signaling prolonged the UVB-induced
edema formation and skin inflammation (Kajiya and Detmar,
2006). These data suggested an active role of lymphatic
vessels in UVB-induced skin inflammation. However, the
molecular mechanism mediating the effects of UVB on the
cutaneous lymphatic system has remained unknown.
Here, we demonstrate that acute UVB irradiation of the
skin induces lymphatic vessel enlargement that is associated
with downregulation of the potent lymphangiogenic factor
VEGF-C. Moreover, intradermal injection of a mutant VEGF-
C protein that selectively activates the VEGFR-3—specifically
expressed by cutaneous lymphatics—attenuated UVB-
induced edema formation and skin inflammation by promot-
ing lymphangiogenesis. Together, these results indicate, for
the first time, that the promotion of lymphatic function might
represent a strategy for preventing UVB-induced skin
inflammation and photodamage.
RESULTS
Acute UVB irradiation induces lymphatic enlargement
associated with macrophage infiltration
To investigate the effects of UVB irradiation on skin
inflammation, mice were exposed to a single UVB irradiation
with 200mJ cm2. Hematoxylin-eosin stains of mouse ear
sections revealed the characteristic features of UVB-induced
skin reactions, including epidermal hyperplasia and dermal
edema formation at 2 and 4 days after UVB irradiation,
whereas the histological appearance of the skin at 8 days after
UVB irradiation was almost comparable to sham-irradiated
skin (Figure 1a–e). Immunohistochemical stains for the
monocyte/macrophage marker CD11b demonstrated a gra-
dual increase in the number of infiltrated macrophages within
the dermis from day 1 to day 4 after UVB irradiation, whereas
the number of macrophages was almost comparable to sham-
irradiated ear skin at day 8 after UVB irradiation (Figure 1f–j).
To analyze the potential involvement of lymphatic vessels in
the UVB-induced inflammation, immunostains for the lym-
phatic-specific hyaluronan receptor LYVE-1 were performed.
A progressive increase in the size of LYVE-1-positive
lymphatic vessels until day 4 was found, whereas lymphatics
adopted their normal, collapsed appearance at 8 days after
UVB irradiation (Figure 1k–o). Computer-assisted morpho-
metric analyses demonstrated that the average tissue area
occupied by lymphatic vessels gradually increased from day
1 to day 4 (Po0.01 on days 1, 2, and 4) after UVB irradiation,
as compared to nonirradiated mice (Figure 1p). Accordingly,
a significant increase in the average size of individual
lymphatic vessels was also found (Po0.05 on day 1,
Po0.01 on day 2, and Po0.001 on day 4) compared to
mouse skin without UVB irradiation (Figure 1q). In contrast,
the density (number per area unit) of lymphatic vessels was
comparable between nonirradiated skin and UVB-irradiated
skin (Figure 1r).
Acute UVB irradiation results in downregulation of VEGF-C
expression
Previously, we found that blockade of the VEGFR-3, the
major receptor for the lymphangiogenic factor VEGF-C,
prolonged UVB-induced edema formation and inflammation
(Kajiya and Detmar, 2006), suggesting a potential functional
role of the VEGF-C/VEGFR-3 pathway in UVB-induced skin
inflammation. To investigate the potential molecular basis for
the observed lymphatic enlargement after UVB irradiation,
we next performed quantitative real-time RT-PCR analyses of
VEGF-C mRNA expression in lysates of UVB-irradiated skin.
We found a significant downregulation of VEGF-C mRNA
expression levels after a single UVB exposure, starting at day
1 after UVB irradiation and lasting until day 4 (Po0.05 on
day 1, Po0.001 on day 2 and day 4). The VEGF-C expression
was comparable to the normal level observed in nonirra-
diated skin at 8 days after UVB irradiation (Figure 2a). To
determine which cells expressed VEGF-C, immunofluores-
cence analysis for VEGF-C was performed. Constitutive
expression of VEGF-C was found predominantly in the
epidermis of nonirradiated skin (Figure 2b), whereas the
VEGF-C expression was strongly downregulated in the
epidermis of UVB-irradiated skin (Figure 2c and d). There-
after, the VEGF-C expression at 8 days after UVB irradiation
was almost the same as in the control skin (Figure 2e). In
contrast, double immunofluorescence analyses for VEGF-C
and CD11b revealed that CD11b-positive macrophages also
expressed VEGF-C in the dermis at day 2 and day 4 after UVB
irradiation (Figure 2g and h) as compared to the skin without
UVB (Figure 2f), however the total amount of VEGF-C in skin
was significantly decreased after UVB irradiation as eval-
uated by real-time RT-PCR (Figure 2a). Additionally, dermal
fibroblasts were irradiated with 20mJ cm2 of UVB in
culture, and VEGF-C concentration was measured by ELISA,
revealing that VEGF-C was downregulated at 24 hours
after UVB (103±6.5 pgml1 in the nonirradiated fibroblasts
and 59±6.6 pgml1 in the UVB-irradiated fibroblasts,
P¼0.0042), whereas no significant difference was found
between two groups at 48 and 96 hours after UVB (data not
shown).
Intradermal injection of a VEGFR-3-specific mutant VEGF-C
protein enhances the recovery from UVB-induced edema
formation and inflammation
To investigate whether activation of the VEGF-C/VEGFR-3
signaling pathway might play a protective role in the control
of UVB-induced skin inflammation, hairless mice were
exposed to 200mJ cm2 of UVB irradiation and were treated
daily—beginning one day before UVB irradiation—with an
intradermal injection of phosphate-buffered saline (PBS) or
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with mutant VEGF-C protein (Cys156Ser), which specifically
activates VEGFR-3 but not VEGFR-2 on lymphatic endo-
thelium (Joukov et al., 1996), into the ears. The extent of
inflammatory ear swelling was found to be comparable in the
PBS-injected and the VEGF-C-injected mouse ears until day 2
after UVB irradiation, whereas beginning from day 3 after
UVB irradiation, the ear thickness of VEGF-C-injected mice
was strongly decreased (24% at day 3, P¼ 0.26; 39% at
day 4, P¼0.016; Figure 3a).
We next investigated whether the observed reduction in
ear thickness after VEGF-C treatment was associated with
detectable histological changes of the skin. Routine histology
stains at day 4 after UVB irradiation revealed that the ear skin
of PBS control-treated mice still displayed the characteristic
features of acute photodamage, including epidermal hyper-
plasia and edema formation in the dermis (Figure 3b). In
contrast, the histological appearance of VEGF-C-treated ear
skin was almost comparable to that of non-UVB-irradiated
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Figure 1. Acute UVB irradiation induces lymphatic vessel enlargement associated with macrophage infiltration. (a–j) Hematoxylin-eosin stains (a–e) and the
immunohistochemistry against an antibody of CD11b in brown (f–j) revealed epidermal hyperplasia, edema formation, and macrophage infiltration in the dermis
after UVB irradiation, whereas the histology of ear skin on day 8 after UVB irradiation resembled the skin without UVB. (k–o) Immunohistochemical analysis of
mouse skin for LYVE-1 (brown) revealed the enlargement of LYVE-1-positive lymphatic vessels of the skin from day 1 to day 4 after UVB irradiation. In contrast,
on day 8, the histology of lymphatic vessels was almost comparable to the skin without UVB. Scale bars¼ 100mm. (p–r) Morphometric analyses of LYVE-1-
stained sections demonstrated a significant increase of area occupied by lymphatic vessels and an average size of lymphatic vessels from day 1 to day 4 after
UVB irradiation, followed by the normalization on day 8. In contrast, the density of lymphatic vessels of the UVB-irradiated skin was comparable to that without
UVB. Data are expressed as mean±SD. *Po0.05; **Po0.01; ***Po0.001.
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skin (Figure 3c). Immunohistochemical stains for CD11b
demonstrated a decreased number of infiltrating macro-
phages in the dermis of VEGF-C-injected ears as compared to
PBS-injected ears (Figure 3d and e).
VEGF-C attenuates UVB-induced inflammation by promoting
lymphangiogenesis
To analyze how activation of the VEGFR-3 pathway by
VEGF-C attenuated the edema formation induced by UVB,
we next performed immunohistochemical studies using
antibodies against LYVE-1 or the blood vascular marker
Meca-32. No major differences in the number or size of
blood vessels were found after VEGF-C treatment of UVB-
irradiated ear skin (Figure 4a and b). In contrast, the number
of LYVE-1-positive lymphatic vessels was strongly increased
in the VEGF-C-injected mouse ears, as compared to control-
treated mice (Figure 4c and d). Moreover, the UVB-induced
lymphatic enlargement was reversed by VEGF-C treatment.
Morphometric image analyses revealed that there was no
significant difference of the size of individual blood vessels,
the tissue area occupied by blood vessel, or the density of
blood vessels between the PBS- and VEGF-C-treatment
groups (Figure 4e–g). Importantly, however, the average size
of lymphatic vessels was significantly decreased in the VEGF-
C-treated skin (21%; Po0.05; Figure 4h), and there was a
pronounced increase in the number of lymphatic vessels
(þ 62%; Po0.001; Figure 4j). Double immunofluorescence
stains for the lymphatic marker LYVE-1 and the proliferation
marker Ki67 revealed proliferating lymphatic endothelial
cells in the ear skin of mice treated with VEGF-C (Figure 4l),
but not in the PBS-treated mice (Figure 4k).
DISCUSSION
Our results reveal, for the first time, that the lymphatic
enlargement after acute UVB irradiation of the skin is
triggered by the UVB-mediated downregulation of the
lymphangiogenic factor VEGF-C, and that promotion of
lymphangiogenesis by intradermal injection of VEGF-C
accelerates the resolution of UVB-induced edema and skin
inflammation.
Edema is a cardinal feature of UVB-induced inflammation,
resulting from the accumulation of extracellular fluid due to
excess leakage from hyperpermeable blood vessels (Persson,
1986) and, as we have shown in a previous study (Kajiya
et al., 2006), due to a failure of lymphatic vessels to
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Figure 2. The VEGF-C expression is downregulated in the epidermis of acute
UVB-irradiated skin. (a) Quantitative real-time RT-PCR showed the
expression of VEGF-C was strongly downregulated starting from day 1 to day
4 after UVB irradiation, whereas, on day 8, the VEGF-C expression in the
epidermis was almost identical to that of non-UVB-irradiated skin. (*Po0.05,
***Po0.001) (b–e) Immunofluorescence analysis for VEGF-C in red revealed
the downregulation of VEGF-C in the epidermis of UVB-irradiated skin. (f–i)
Double immunofluorescence staining of VEGF-C (green) and CD11b (red)
demonstrated that CD11b-positive macrophages in the dermis also expressed
VEGF-C at day 2 and day 4 after UVB irradiation. Scale bars¼ 100mm.
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Figure 3. The injection of mutant VEGF-C attenuates UVB-induced edema
formation and inflammation. (a) Ear swelling is expressed as the increase in
thickness over pre-irradiation value. No significant difference was found
between vehicle-injected mouse ears (~) and mutant VEGF-C-injected
groups (m) during the first two days after UVB irradiation. On day 4 after UVB
irradiation, ear swelling was still observed in the ears treated with vehicle,
whereas the VEGF-C-injected mouse ears showed attenuated ear swelling
(*Po0.05). Data are expressed as mean±SEM (N¼ 5). (b and c) Histological
analysis revealed the ear skin of vehicle-treated mice still showed marked
edema formation and vessel dilation in the dermis, whereas the VEGF-C-
injected mouse ears were similar to non-UVB-irradiated skin. (d and e)
Immunohistochemistry for CD11b in brown revealed decreased macrophage
infiltration in the dermis of ear skin treated with mutant VEGF-C (e), compared
to vehicle-treated ears (d). Scale bars¼ 100 mm.
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sufficiently drain the fluid from the interstitium. Overall, the
decreased drainage function of lymphatic vessels leads to
overextension of these lymphatics (Skobe and Detmar, 2000)
and also to reduced clearance of inflammatory macrophages
from the tissue via lymphatic drainage. This concept is
supported by our current data, which demonstrate that UVB-
induced macrophage infiltration was most abundant during
the stage of lymphatic vessel enlargement during days 2–4
after UVB irradiation, whereas only a few CD11b-positive
cells were found in the skin on 8 day after UVB irradiation
when lymphatic vessels had returned to their normal
collapsed shape. Together, these results reveal a previously
unanticipated role of the lymphatic vascular system in
promoting the clearance of cutaneous inflammation, and
they are in agreement with the increased occurrence of skin
inflammation in patients with chronic lymphedema (Cueni
and Detmar, 2006).
The molecular mechanisms controlling the vascular
reaction in UVB-irradiated skin have only recently begun to
be elucidated. UVB-induced blood vascular leakage and
angiogenesis appear to be mediated by upregulation of the
angiogenesis factor VEGF-A and by downregulation of the
endogenous angiogenesis inhibitors thrombospondin-1 (Yano
et al., 2004) and IFN-b (Bielenberg et al., 1998). Recently, we
have surprisingly found that UVB-mediated upregulation of
epidermal VEGF-A expression also results in hyperperme-
ability of cutaneous lymphatic vessels, thus reducing their
fluid draining capacity—likely via activation of VEGFR-2 on
lymphatic endothelium (Kajiya et al., 2006). Accordingly,
systemic treatment with a VEGF-A blocking antibody resulted
in diminished edema and a reduction in the size of lymphatic
vessels in the skin (Kajiya et al., 2006). These results are in
accordance with the recent discovery that—during skin
inflammation induced by experimental delayed-type hyper-
sensitivity—VEGF-A promoted enlargement of lymphatic
vessels in the dermis as well as in the draining lymph nodes,
thereby enhancing the inflammatory response (Kunstfeld
et al., 2004; Halin et al., 2007), and that systemic inhibition
of VEGF-A signaling inhibited experimental inflammation
associated with a decrease in the size of lymphatic vessels
(Kunstfeld et al., 2004). Taken together with the findings that
adenoviral delivery of VEGF-A to mouse ear skin induced
hyperplasia of nonfunctional lymphatic vessels (Nagy et al.,
2002), these results indicate that activation of VEGF-A
signaling in the skin prolongs the inflammatory responses
by inhibition of lymphatic drainage function. In addition, as
previously shown, VEGF-A also contributes to prominent
dilation and activation of blood vessels, thereby facilitating
the infiltration of inflammatory cells into the inflamed skin
(Dvorak, 2005).
In contrast to VEGF-A, the role of VEGF-C in inflammation
has remained unknown. Recent studies in mice have
indicated that chronic airway inflammation—induced by
Mycoplasma pulmonis infection—is accompanied not only
by angiogenesis, but also by lymphatic hyperplasia, and that
inhibition of lymphatic vessel function by blockade of the
VEGFR-3 pathway causes exaggerated mucosal edema,
leading to airflow obstruction (Baluk et al., 2005). Moreover,
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Figure 4. Activation of VEGFR-3 pathway promotes the recovery from UVB-
induced inflammation by inducing lymphangiogenesis. (a and b)
Immunohistochemistry using an antibody for blood vessel specific antigen,
panendothelial antigen-1 in brown revealed no major differences between
vehicle-treated mouse ears and the ear skin injected with VEGF-C.
(c and d) Immunohistological analysis of ear sections with LYVE-1 in brown
demonstrated that the enlarged lymphatic vessels were still found in vehicle-
treated ear (c), not in mouse ear treated with mutant VEGF-C (d).
Morphometric analysis using the sections stained for panendothelial antigen-1
(e–g) and LYVE-1 (h–j) revealed that no significant difference was found in the
blood vessels between vehicle-treated and VEGF-C-treated mouse ears,
whereas the average size of lymphatic vessels (h) was significantly decreased
in the VEGF-C-injected mouse ears compared to ears treated with vehicle.
Moreover, the density of lymphatic vessels of ear skin injected with VEGF-C
was increased as compared to vehicle-treated skin (j). Data are expressed as
mean±SD. (k and l) Double immunofluorescence using antibodies for Ki67
(red) and LYVE-1 (green) demonstrated that more proliferating lymphatic
endothelial cells were found in the VEGF-C-treated ears (l) compared to the
vehicle-treated ears (k). Scale bars¼100 mm. *Po0.05, ***Po0.001, n.s: not
significant.
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systemic blockade of VEGFR-3 signaling prolongs UVB-
induced edema formation and inflammation in the skin
(Kajiya and Detmar, 2006). Taken together, these recent data
suggested us that VEGF-C-mediated activation of the VEGFR-
3 pathway in lymphatic endothelium might possibly play an
important role in counteracting the pro inflammatory effects
of VEGF-A that are mediated via VEGFR-2. To address this
hypothesis, we have used intradermal injections of a mutant
VEGF-C protein—that specifically activates VEGFR-3 but not
VEGFR-2—into mouse ears together with UVB irradiation.
Our results clearly demonstrate that ear swelling was strongly
reduced on day 4 after UVB irradiation, at a time point when
the endogenous VEGF-C expression was most strongly
downregulated. It is of interest that intradermal injection of
VEGF-C induced proliferation of lymphatic endothelial cells
in the dermis, resulting in lymphangiogenesis that might
promote the efficient drainage of tissue fluid from the
inflamed skin. Our data are in agreement with results
obtained in wound repair models where injection of VEGF-
C promoted the formation of new functional lymphatic
vessels after experimental resection of cutaneous lymphatics
in the rabbit ear (Saaristo et al., 2004). As VEGF-C—after
enzymatic cleavage—can also activate VEGFR-2 on lympha-
tic endothelial cells (Joukov et al., 1997), further studies are
needed to determine the distinct molecular mechanisms of
VEGF-C-mediated activation of the VEGFR-3 pathway versus
the VEGFR-2 pathway. Moreover, a number of additional
lymphangiogenic factors have been recently identified, such
as hepatocyte growth factor (Kajiya et al., 2005), VEGF-D,
angiopoietin-1, platelet-derived growth factor-BB, and adre-
nomedullin (Jurisic and Detmar, 2008), and their relative
contribution to the control of UVB-induced skin inflamma-
tion remains to be clarified.
In summary, our results indicate that UVB irradiation of
the skin impairs the clearance function of cutaneous
lymphatic vessels with regard to drainage of tissue fluid and
inflammatory macrophages, and that stimulation of lympha-
tic function and lymphangiogenesis via induction of VEGF-C
might represent a strategy to treat or prevent cutaneous
photodamage.
MATERIALS AND METHODS
UVB irradiation regimen
A total of 18 female albino HR-1 hairless mice (Hoshino Laboratory
Animal Co. Ltd, Saitama, Japan) at 8 weeks of age were exposed to a
single dose of 200mJ cm2 of UVB irradiation as described (Yano
et al., 2002), using 10 Toshiba FL-20 SE fluorescent lamps that
deliver energy in the UVB (280–340nm) wavelength range with a
maximum energy at a wavelength of 305 nm. At days 0, 1, 2, 4, and
8 after UVB irradiation, three mice each were killed and the ears
were fixed with cold acetone (AMeX procedure), embedded in
paraffin, and processed for histological analysis (Sato et al., 1986).
Ears were cut in half to obtain samples for RNA extraction and for
analyzing histology.
In an additional study, a total of 10 female albino HR-1 hairless
mice at 8 weeks of age were exposed to a single dose of 200mJ cm2
of UVB irradiation. Beginning 1 day before UVB irradiation, the right
ears of five mice were treated daily until day 3 after UVB irradiation
(five times total) by intradermal injection with 100 ng recombinant
VEGF-C (Cys156Ser; R&D Systems, Minneapolis, MN), dissolved in
1ml. In contrast to wild-type VEGF-C, which can activate both
VEGFR-3 and VEGFR-2, VEGF-C (Cys156Ser) only binds to VEGFR-3
expressed on lymphatic endothelial cell (Veikkola et al., 2001). The
left ears were injected with an equal volume of vehicle only. The
thickness of the ears was measured daily until day 4 after the UVB
irradiation. At 4 days after the UVB irradiation, mouse ears were
fixed in cold acetone and were processed for histological analysis of
paraffin sections. All procedures including intradermal injections
and measurements of ear thickness were performed under anesthesia
with pentobarbital. All animal studies were approved by the Shiseido
Research Center Committee on Research Animal Care.
Immunostains and computer-assisted morphometric vessel
analysis
Immunohistochemical analyses were performed as described (Kajiya
et al., 2007, 2008), using antibodies against the macrophage
monocyte marker CD11b (BD Biosciences, Bedford, MA), the blood
vessel-specific marker Meca-32 (BD Biosciences; Vittet et al., 1996),
the lymphatic-specific marker LYVE-1 (Upstate, Lake Placid, NY;
Banerji et al., 1999), or VEGF-C (kindly provided by Dr K Alitalo,
Helsinki, Finland; Baluk et al., 2005). Routine hematoxylin-eosin
stains were also performed. Sections were examined with an
Olympus AX80T microscope (Olympus, Tokyo, Japan) and images
were captured with a DP controller digital camera (Olympus).
Morphometric analyses were performed using the IP-LAB software as
described (Kajiya et al., 2005). Three different fields of each section
were examined and the number of vessels per square micrometer,
the average vessels size and the relative tissue area occupied by
lymphatic vessels in the dermis were determined. The unpaired
Student’s t-test was used to analyze differences in microvessel
density and size.
Quantitative real-time RT-PCR
Total cellular RNA was isolated from mouse ears using Trizol
(Invitrogen, Carlsbad, CA) and was treated with RQ1 RNase-free-
DNase (Promega, Madison, WI) as previously described (Ishimatsu-
Tsuji et al., 2005). Briefly, the ear skin was cut into small (0.5 cm)
pieces and frozen quickly in liquid nitrogen. The frozen skin pieces
were physically crushed with a Cryo-press apparatus (Microtec,
Funabashi, Japan) for 45 seconds. Each powdered sample was
dissolved in 1ml Trizol, and total RNA was isolated. The expression
of mouse VEGF-C mRNA was investigated by quantitative real-time
RT-PCR, using the ABI Prism 7000 Sequence Detection System
(Applied Biosystems, Foster City, CA). The primers and probe for
VEGF-C were described previously (Kunstfeld et al., 2004). Expres-
sion levels were normalized by glyceraldehyde-3-phosphate dehy-
drogenase expression levels (primers: forward 50-TCACTGGCATG
GCCTTCC-30, reverse 50-GGCGGGCACGTCAGATCCA-30), and
probe (50-FAM-TTCCTACCCCCAATGTGTCCGTCG-TAMRA-30) as
an internal control.
Cell culture and ELISA
IMR91 fibroblasts were cultured in DMEM (Gibco BRL, Grand
Island, NY) supplemented with 10% fetal bovine serum (Life
Technologies, Paisley, UK) and 2mM glutamine. IMR91 fibroblasts
were irradiated with 20mJ cm2 of UVB and at 0, 24, 48, and
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96 hours after UVB irradiation, supernatants were collected and
VEGF-C concentration was analyzed by ELISA (Bender, Vienna,
Austria). Nonirradiation supernatants were also obtained as controls.
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